The in vivo rat micronucleus test: integration with a 14-day study.

A 14-day subchronic toxicity study is routinely conducted in Fischer 344 rats at the Lilly Research Laboratories. This study is done to gather preliminary toxicological information about chemical entities showing efficacy in various pharmacological screens. This manuscript describes the validation of a method for evaluating micronuclei in the bone marrow polychromatic erythrocytes of animals from this test in order to obtain additional information about the genotoxic potential of these compounds without incurring the cost of additional animals or the use of additional test article, which is often in limited supply. Compounds selected for evaluation were acetylsalicylic acid, mitomycin C, cyclophosphamide, colchicine, 6-mercaptopurine, and etoposide. With the exception of colchicine, the results obtained were as expected with acetylsalicylic acid yielding negative results and the other compounds yielding positive results. These findings are consistent with those published for mice (MacGregor et al., Fund. Appl. Toxicol., 14, 513-522, 1990) and show that a bone marrow micronucleus test can be successfully integrated into a routine subchronic rat toxicology study.

Diphenylhydantoin is not genotoxic in a battery of short-term cytogenetic assays.

5,5-Diphenylhydantoin (DPH) is an antiepileptic drug associated with an increase in malformations in infants born to women taking DPH during pregnancy. Positive and negative results have been reported by various investigators for in vivo and in vitro chromosome aberration (CAB) assays, in vivo and in vitro sister chromatid exchange (SCE) assays, and in vivo micronucleus tests (MNT). In this laboratory, DPH was tested in an in vitro CAB assay using Chinese hamster ovary cells with and without an S-9 activation system, an in vivo SCE assay in female CD-1 mice, an in vivo MNT, using both male and female CD-1 mice, and a transplacental micronucleus test. The results from this comprehensive battery of cytogenetic tests were uniformly negative and support a conclusion that the known teratogen, DPH, is not clastogenic.